| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |